• Casdin Partners Master Fund, a 10% owner of BioLife Solutions, sold 1.2 million common shares from May 19 to May 21 at prices ranging from $22.65 to $23.7.
• Holdings fell to 4,757,165 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioLife Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000919574-26-003646), on May 21, 2026, and is solely responsible for the information contained therein.